Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potent MMP inhibitor delays osteolytic disease associated with breast cancer metastasis

Dec. 18, 2000

S-1 appears to safely improve survival in metastatic breast cancer patients

Dec. 18, 2000

Arzoxifene has identical effects to tamoxifen in endometrial cancer models

Dec. 18, 2000

EntreMed commences phase I trial of Angiostatin by s.c. injection

Dec. 18, 2000

Cytochroma collaborates with Johns Hopkins on vitamin D-related drug discovery

Dec. 18, 2000

ODAC unanimously recommends approval of Femara as first-line breast cancer treatment

Dec. 15, 2000

New progesterone receptor modulators continue to emerge from AHP/Ligand alliance

Dec. 15, 2000

Genetic Therapy constructs promising new antiangiogenic gene therapy

Dec. 15, 2000

Carborane-based retinoid receptor antagonists presented at recent scientific meeting

Dec. 15, 2000

Praecis seeks FDA approval of abarelix depot for prostate cancer

Dec. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...